Many human genetic disorders and diseases are known to be related to each other through frequently observed co-occurrences. Studying the correlations among multiple diseases provides an important avenue to better understand the common genetic background of diseases and to help develop new drugs that can treat multiple diseases. Meanwhile, network science has seen increasing applications on modeling complex biological systems, and can be a powerful tool to elucidate the correlations of multiple human diseases. In this article, known disease-gene associations were represented using a weighted bipartite network. We extracted a weighted human diseases network from such a bipartite network to show the correlations of diseases. Subsequently, we proposed a new centrality measurement for the weighted human disease network in order to quantify the importance of diseases. Using our centrality measurement to quantify the importance of vertices in the weighted human disease network, we were able to find a set of most central diseases. By investigating the 30 top diseases and their most correlated neighbors in the network, we identified disease linkages including known disease pairs and novel findings. Our research helps better understand the common genetic origin of human diseases and suggests top diseases that likely induce other related diseases.
Introduction

1
During the past decades, significant progress has been made in our understanding of 2 human diseases [1] . However, the genetic architectures of complex diseases are still 3 largely unclear. Many common diseases tend to be related to each other, and it is 4 suspected that they may share common genetic origin. Thus, studying the correlations 5 of human diseases has the potentials of better understanding the genotype to phenotype 6 mapping [2, 3] and better predicting disease association genes [4, 5, 6, 7, 8] .
tailored centrality measures are needed for specific network of interest, in this study, the 48 human disease network. 49 Köhler et al. [39] proposed a vertex importance measure for disease genes in the 50 context of PPI networks. They used a random walk strategy to assess the distance 51 between vertices in the network, and reported improved performance comparing with 52 conventional distance-based centrality measures. Wu et al. [40] integrated PPI networks 53 with gene expression data in order to rank disease genes associated with various cancers. 54 They showed that their method was able to find replicable high-rank genes using 55 different datasets. Martinez et al. [41] proposed a generic vertex prioritization method 56 using the idea of propagating information across data networks and measuring the 57 correlation between the propagated values for a query and a target set of entities. The 58 authors tested their method by ranking disease genes associated with Alzheimer's 59 disease, diabetes mellitus type 2 and breast cancer. They reported some new high-rank 60 association genes that could bring new insights into the diseases. 61 In the article, we propose a new method for the construction of a weighted human 62 disease network (WHDN) and a new centrality measure to identify the most important 63 diseases. First we use a large database of disease-gene associations to build a weighted 64 bipartite disease-gene network, and then construct a weighted disease network where incident edges. Finally, we compare our new centrality measure with degree, closeness 69 and betweenness by evaluating the network efficiency decline rate with the removal of 70 top-ranked vertices by each centrality measurement. 71 
Methods and Results
72
Given the multiple-step pipeline structure of this study, we show the result of each step 73 after the description of the corresponding method. 74 Disease-Gene Associations (DGAs) 75 The data used in this project contains disease-gene associations (DGAs) from multiple 76 curated databases including UNIPROT, CTD (human subset), PsyGeNET functions. We use DisGeNet web-based application [42] for this filtering.
90
Network Construction
91
Bipartite Disease-Gene Association Network
92
The best representation for depicting the associations among genes and diseases is a 93 bipartite graph, which is called the disease-gene association network in this research.
94
The bipartite graph contains two different sets of vertices. One set includes diseases and 95 another one contains genes. By definition, no edge is allowed to connect a pair of 96 vertices in the same set of vertices in a bipartite graph. That is, there can be no link 97 either between a pair of diseases or a pair of genes. There is an edge between a gene 98 and a disease if there is an association between them. Their link weight is assigned as 99 the score a k i , for disease i and gene k, computed in the DGA database described in the 100 previous section. A sample subgraph of the bipartite network is shown in Figure 1 . Figure 2 depicts the degree distributions of diseases and genes in the bipartite 102 disease-gene association network. For the set of diseases, the maximum degree is 564, of 103 the disease epilepsy, and the average degree is 5.43. In Figure 2 a), the degree Fig 1. An example subgraph of the human disease-gene association network. The bipartite network has two sets of vertices, i.e., genes and diseases, represented by rectangle and gray ellipses respectively. An edge connects a disease and a gene if there is a known association between them. The weight of an edge indicates the strength of the DGA a k i between disease i and gene k. Here, similarly, first we consider that the correlation of two diseases through a gene 135 is stronger when they are the sole associated diseases with this gene than when there 136 are many other diseases associated with the same gene. Second, the correlation of two 137 diseases is considered stronger when they share more genes through stronger 138 associations than less genes or weaker associations. Thus, we extend Newman's method 139 to weighted graph and define the weight of edge w ij between two diseases i and j as
where δ k i is one if disease i and gene k have a DGA, and zero otherwise. a k i is the score 141 of their DGA assessed by DisGeNET as discussed in the previous section, and s k is the 142 strength of gene k as a vertex in the bipartite disease-gene network, defined as the sum 143 of the scores of the DGAs between gene k and its directly linked diseases, 
Such a weight definition indicates that the correlation strength of two diseases is
145
weighted inversely according to the strengths of the genes they share, and is
146
proportional to the total number of genes they share and the strengths of their DGAs. 147 For example, in Figure 1 , the weight between diseases contact dermatitis (CD) and white sponge nevus 1 (WSN1) is calculated as follows,
Note that the weight of two diseases can be greater than one when they share multiple genes. For example the weight between diseases WSN1 and hereditary mucosal Leukokeratosis (HML) is calculated as follows, Figure 4 depicts the distribution of all the edge weights in the 154 WHDN. As we can see that a large number of edge weights are of small values and may 155 not be particularly interesting for the subsequent analysis. Those weak edges not only 156 add computational overhead to the network analysis, but also render the network 157 difficult to interpret. Therefore, next we perform an edge reduction and only extract the 158 most meaningful structure of the network.
159
The Multi-Scale Backbone of WHDN
160
The most straightforward strategy for network reduction is to use a global weight 161 threshold and remove all links that have weights lower than the threshold. However, 162 such a global thresholding strategy is somewhat arbitrary and may overlook the network 163 information present below the cutoff scale. Here, to preserve the multi-scale backbone of 164 the weighted human disease network (WHDN) while removing less relevant and meaningful edges we use a multi-scale filtering method proposed by Serrano et al. [43] . 166 Such a multi-scale backbone exaction algorithm has been used to reduce the network 167 size while preserving the meaningful structure of biological networks in multiple 168 studies [32, 44, 45, 46] .
169
First, the weight of edge linking vertex i with its neighbor j can be normalized as
where s i is the vertex strength, i.e., the sum of weights incident to vertex i, defined as 171
where (i) produced by a random assignment from an uniform distribution. Thus the probability 178 density function for the variable taking a particular value x is
Then, to identify whether the probability, β ij , of link weight p ij is compatible with 180 the null model with a threshold β is given as
All links with computed β ij lower than a given threshold β are preserved in the lower than β, the link will be preserved. In the second case, an edge is preserved if both 185 β ij and β ji are lower than β. Darabos et al. [44] empirically found that the AND rule 186 preserve the network features better than using the OR rule in the context of human 187 phenotype networks. In this article, the AND rule is adopted to reduce the size of the 188 network by removing the links which are less relevant.
189
To find the best cutoff for β, we calculate clustering coefficient, percentage of 190 remaining vertices and links, and total weight of the networks after applying a β cutoff 191 while β changes from 0 to 1. Figure 5 shows the results of network metrics as a function 192 of β cutoffs. We choose a β cutoff when the clustering coefficient and the remaining 
196
After the backbone extraction, the WHDN has 4,898 vertices and 38,275 edges.
197
Those vertices are no longer connected in a single component. Figure 6 shows the size 198 distribution of its connected components. There is a giant component with 4,810 199 vertices and its degree distribution is shown in Figure 7 . Again the degree distribution 200 is heavy tailed and resembles a power-law relationship. The vertex epilepsy has the 201 highest degree of 576. This giant component will be the focus for our next step analysis, 202 i.e., measuring vertex importance in order to find the most central diseases in terms of 203 correlating with other diseases. Measuring Vertex Importance in WHDN graphs, we name it the DIL-W centrality.
218
First, in the context of unweighted graph, the importance of a link e ij that connects 219 vertex v i and v j can be calculated as follows:
where U eij = (k i − p − 1)(k j − p − 1) and λ eij = p 2 + 1. Following the convention, k i and 221 k j are the degrees of vertex v i and v j , respectively, and p is the number of triangles 222 with one edge being e ij .
223
Subsequently, the contribution that vertex v i makes to the importance of e ij is 224 computed as
where j ∈ Γ i , and Γ i is the neighborhood of vertex i.
226
Then, the DIL centrality of vertex v i is calculated by combining both its degree and 227 the importance of its incident links,
For weighted networks, we modify the computation of U in Equation (7) as
where s i is the strength of vertex v i , calculated by Formula (4), and p i is the weight that first an edge is considered more important when its two end vertices have higher 232 strengths. Second, the importance of an edge is reduced when it has alternative two-hop 233 paths connecting the same set of end vertices. Therefore, we subtract p i from s i in 234 Equation (10).
235
We define λ for weighted graphs as
Finally, the importance of a vertex can be measured by
where C vivj is defined as
In the weighted graph given in Figure 8 , vertex a has a higher strength but a lower 239 degree than vertex b. We compute their DIL-W centralities and investigate which one is 240 more central when both factors are considered. 
where
and
We have p a = w ac + w ag = 0.3 + 0.6 = 0.9, and p b = w bc + w bg = 0.2 + 0.7 = 0.9. Similarly, we can compute the DIL-W centrality of vertex b DIL-W b = 2.8916.
242
Therefore, based on both the degree and importance of incident edges, vertex a is 243 considered more important than vertex b.
244
We apply the DIL-W centrality measurement to the giant component of the 245 backbone of WHDN, the distribution is shown in Figure 9 . 
Here d w ij denotes the weighted distance between vertex i and j, and w ih is the weight of 256 the edge linking vertex i and h. Since in our WHDN edge weight suggests strength, the 257 distance between two vertices is the minimum sum of the inverse of edge weight along 258 the path connecting them. Once the weighted distance is defined, closeness and 259 betweenness can be calculated by their original definitions. 
265
To evaluate our new vertex importance quantification method, DIL-W, we measure 266 the network efficiency before and after we remove the most important vertices in the 267 WHDN. In the context of the WHDN, the network efficiency indicates the extend to 268 which the original connectivity of the network is maintained. We calculate the decline 269 rate of network efficiency after removing m top-rank vertices. The network 270 efficiency [48] is computed based on the connectivity of a network. A higher 271 connectivity suggests a higher network efficiency. The network efficiency is defined by 272
where n is the total number of vertices in the network, V is the vertex set, and d ij is 273 the weighted distance between vertex v i and v j . Thus, the decline rate of the network 274 efficiency is calculated as
where η 0 is the efficiency of the original network, and η is the network efficiency after 276 some vertices are removed. When a more importance vertex is removed, we expect to see a greater decline rate 278 of the network efficiency. Thus we can use µ as a indicator for the actual impact of 279 removing a vertex in the network. Figure 11 shows the decline rate of the network vertices could be investigated but was not included in the current study given the high 283 computational demand. As shown in the figure, we do not observe a monotonic 284 relationship across all four centrality methods. However, the correlation analysis shows 285 that our method, DIL-W, has a slighter stronger negative correlation between the 286 decline rate and the rank of the removed vertex than the other three. The Spearman's 287 rank correlation coefficient, ρ, for degree, closeness, and betweenness is −0.1801,
288
−0.0017, and −0.0679, respectively. In comparison, DIL-W has a negative correlation 289 coefficient −0.2698.
290
We also consider removing all m top-rank vertices at once and see how this 291 accumulative removal affects the efficiency of the network. Figure 12 shows the decline 292 rate of the network efficiency after removing all top m vertices ranked by different 293 centrality measures. The graph shows that the proposed method, DIL-W, has the 294 highest decline rate of network efficiency for 57.5% of the data points, while 295 betweenness, closeness, and degree have 27.5%, 10%, and 5%, respectively. This 296 suggests that DIL-W is able to select a set of more important vertices comparing with 297 the other three centrality measures. As seen in Figure 12 , the four methods are very 298 comparable until the top 11 diseases are removed from the network. Then DIL-W has a 299 significant higher network efficiency decline rate than the rest. Betweenness centrality 300 catches up around point 30 and becomes very comparable afterwards. Table 1 shows the top 30 diseases ranked by our DIL-W method, their degrees, and 302 their neighbors that have the strongest correlations (i.e., edge weights). References that 303 support the known comorbidity of the disease pairs are also given. In this article, we use a network-based analysis to identify important human diseases 306 that share genetic background with many other diseases through strong associations.
301
307
We collect a large number of known disease-gene associations (DGAs) using DisGeNET 308 in order to construct a bipartite disease-gene network. Subsequently, a weighted human 309 disease network (WHDN) is built by connecting pairs of diseases that share associated 310 genes and the edge weights reflect the number of genes they share as well as the identified top diseases including epilepsy, anemia, and obesity.
316 Table 1 shows the degree in the WHDN and the most correlated disease of those 30 317 top-rank diseases. We are also able to find previous publications that verify almost all 318 the correlations of those pairs of diseases, shown as references in the table. Besides some 319 very well-known correlations such as heart failure -obesity and diabetes -obesity, the 320 table also reports some less known but interesting correlations. For instance, Savin [49] 321 showed that atypical retinitis pigmentosa is correlated with obesity. Moreover, the literature until recently Dimmock et al. [50] suggested anemia as one of the novel causes 324 of failure to thrive in children. Zimmerman [51] 
